Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Return on Assets (2021 - 2025)

Historic Return on Assets for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to 0.42%.

  • Relay Therapeutics' Return on Assets fell 200.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.39% for FY2024, which is 400.0% down from last year.
  • Per Relay Therapeutics' latest filing, its Return on Assets stood at 0.42% for Q3 2025, which was down 200.0% from 0.41% recorded in Q2 2025.
  • In the past 5 years, Relay Therapeutics' Return on Assets registered a high of 0.09% during Q1 2021, and its lowest value of 0.43% during Q4 2021.
  • Moreover, its 5-year median value for Return on Assets was 0.38% (2021), whereas its average is 0.35%.
  • In the last 5 years, Relay Therapeutics' Return on Assets tumbled by -4000bps in 2021 and then surged by 1800bps in 2022.
  • Over the past 5 years, Relay Therapeutics' Return on Assets (Quarter) stood at 0.43% in 2021, then skyrocketed by 41bps to 0.26% in 2022, then crashed by -53bps to 0.39% in 2023, then rose by 4bps to 0.37% in 2024, then dropped by -13bps to 0.42% in 2025.
  • Its Return on Assets stands at 0.42% for Q3 2025, versus 0.41% for Q2 2025 and 0.4% for Q1 2025.